Disproportionality analysis of adverse events associated with degarelix: a real-world study from the FDA Adverse Event Reporting System (FAERS) database
{{output}}
Purpose: This study aimed to detect adverse event (AE) signals associated with degarelix by analyzing data from the US FDA Adverse Event Reporting System (FAERS), so as to provide evidence for its safe clinical use. ... ...
